Skip to content

LG-365-E

by Laser Peripherals LLC.

LG-365-E is an urogenital surgical laser system beam guide (FDA Class II; FDA product code GEX, Powered laser surgical instrument) made by Laser Peripherals LLC., listed in FDA GUDID since 16 May 2017 (UDI-DI 00816469021094), registry data as of 20 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 20 Oct 2026.

Regulatory status

as of registry sync 20 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00816469021094 UDI-DI Date16 May 2017ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
LaseGuide™ Edge 365u Laser Fiber
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied sterile

From the GUDID record (AccessGUDID), as read on 20 Oct 2026, as the labeller entered it.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Generic name
Urogenital surgical laser system beam guide, single-use
Model / Ref / Catalog
LG-365-E
Primary DI / UDI-DI
00816469021094
FDA product code
GEX
GMDN term
Urogenital surgical laser system beam guide, single-use
Device class
Class II
Regulation number
878.4810
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code GEX (Powered laser surgical instrument).

Other devices from Laser Peripherals LLC.

  • 1150-500

    Class II
  • 1150-50T

    Class II
  • Db-400-Nl

    Class II
  • Lg-272-Cn

    Class II

See all devices from Laser Peripherals LLC. →

Properties

  • Supplied sterile
  • Single use
  • Lot / batch number
  • Expiration date
Other properties (11, all answered No)